Media headlines about ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) have been trending somewhat positive this week, Accern Sentiment reports. The research firm identifies negative and positive news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. ProShares Ultra Nasdaq Biotechnology ETF earned a media sentiment score of 0.06 on Accern’s scale. Accern also gave media stories about the exchange traded fund an impact score of 46.0288478051935 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Shares of ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB) opened at $52.90 on Wednesday. ProShares Ultra Nasdaq Biotechnology ETF has a 12-month low of $38.82 and a 12-month high of $64.51.

ILLEGAL ACTIVITY WARNING: This article was originally reported by Watch List News and is the sole property of of Watch List News. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at https://www.watchlistnews.com/proshares-ultra-nasdaq-biotechnology-etf-bib-receives-daily-media-impact-rating-of-0-06/1718733.html.

About ProShares Ultra Nasdaq Biotechnology ETF

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.

Insider Buying and Selling by Quarter for ProShares Ultra Nasdaq Biotechnology ETF (NASDAQ:BIB)

Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology ETF and related companies with Analyst Ratings Network's FREE daily email newsletter.